The abstract is read at the publisher; the summary is JClub's.
Engineered autophagy receptors delivered by small extracellular vesicles reduce pathological tau and cytoplasmic TDP-43 in neuronal cultures and reduce tau pathology in mice.
- Why it matters: Neurodegenerative diseases involve toxic protein accumulation, but directing intracellular degradation to specific pathological cargos remains challenging.
- What they did: Guo and colleagues fused cytoplasm-stable antibody fragments to LC3A and delivered the constructs via small extracellular vesicles; they also tested an adeno-associated virus approach targeting TDP-43 in mice.
- The result: Selective cargo recognition coupled to intracellular delivery is linked to reduced tau and TDP-43 pathology and, for TDP-43, improved motor performance in mice, informing how receptor design may be adapted across disease contexts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.